Try our Advanced Search for more refined results
October 25, 2021
CURIA IP HOLDINGS, LLC v. SALIX PHARMACEUTICALS, LTD. et al
Case Number:
2:21-cv-19293
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
August 17, 2022
Judge Axes IP Suit Over Xifaxan, Ruling The Drug Is Prior Art
A New Jersey federal judge on Wednesday dismissed an infringement suit against Bausch Health unit Salix Pharmaceuticals Ltd. over its drug Xifaxan after finding the drug product actually constitutes prior art to the four patents it was accused of infringing.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login